Jolien Tol
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 30
- Colorectal Cancer Treatments and Studies 17
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 3
- COVID-19 and healthcare impacts 3
-
- Advanced Breast Cancer Therapies 5
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Cornelis J.A. Punt (14 shared papers)Irıs D. Nagtegaal (7 shared papers)J. Han van Krieken (6 shared papers)Roeland E. Voorrips (1 shared paper)Jan van Dalen (1 shared paper)Jacques van der Meer (1 shared paper)Lambert P.W.J. van den Heuvel (1 shared paper)J. W. Van Ooijen (1 shared paper)
- Journals
- European Journal of Cancer (7 papers)Breast Cancer Research and Treatment (6 papers)International Journal of Cancer (3 papers)Targeted Oncology (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Jolien Tol
48 papers receiving 4.8k citations
Jolien Tol's Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 2.2k
- Hepatology 357
- Pathology and Forensic Medicine 586
- Cancer Research 459
- Plant Science 1.2k
Countries citing papers authored by Jolien Tol
This map shows the geographic impact of Jolien Tol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolien Tol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolien Tol more than expected).
Fields of papers citing papers by Jolien Tol
This network shows the impact of papers produced by Jolien Tol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolien Tol. The network helps show where Jolien Tol may publish in the future.
Co-authors
The 25 scholars most cited alongside Jolien Tol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | JoinMap® 4, Software for the calculation of genetic linkage maps in experimental populations Hit paper breakdown → | 2006 | 1502 |
| 2 | Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 1109 |
| 3 | 2009 | 445 | |
| 4 | 2015 | 405 | |
| 5 | 2010 | 190 | |
| 6 | 2011 | 168 | |
| 7 | 2010 | 149 | |
| 8 | 2012 | 132 | |
| 9 | 2009 | 72 | |
| 10 | 2009 | 70 | |
| 11 | 2010 | 69 | |
| 12 | 2015 | 65 | |
| 13 | 2020 | 62 | |
| 14 | 2012 | 60 | |
| 15 | 2014 | 57 | |
| 16 | 2016 | 47 | |
| 17 | 2024 | 43 | |
| 18 | 2016 | 32 | |
| 19 | 2024 | 32 | |
| 20 | 2023 | 23 |
About Jolien Tol
Jolien Tol is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Hepatology, having authored 49 papers that have together received 4.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (17 papers), HER2/EGFR in Cancer Research (6 papers), Genetic factors in colorectal cancer (5 papers), Advanced Breast Cancer Therapies (5 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Treatment and Pharmacology (3 papers), COVID-19 and healthcare impacts (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (2.2k citations), Hepatology (357 citations), Pathology and Forensic Medicine (586 citations), Cancer Research (459 citations) and Plant Science (1.2k citations). Jolien Tol has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Cornelis J.A. Punt, Irıs D. Nagtegaal, J. Han van Krieken, Roeland E. Voorrips, Jan van Dalen, Jacques van der Meer, Lambert P.W.J. van den Heuvel, J. W. Van Ooijen, JH van Krieken and Jeroen R. Dijkstra. Their work appears in journals such as European Journal of Cancer, Breast Cancer Research and Treatment, International Journal of Cancer, Targeted Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.